Point72 Hong Kong LTD Intercept Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $51,465 - $83,035	4,215 New	4,215 $59,000
Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $157 - $274	-14 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$13.37 - $17.79 $187 - $249	14 New	14 $0
Q4 2021 Feb 14, 2022	SELL	$14.28 - $19.53 $21,605 - $29,548	-1,513 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$12.99 - $20.47 $19,653 - $30,971	1,513 New	1,513 $22,000

Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $65,354 - $127,632	-3,381 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $77,699 - $134,799	3,174 Added 1533.33%	3,381 $84,000
Q3 2020 Nov 16, 2020	BUY	$39.09 - $53.44 $8,091 - $11,062	207 New	207 $9,000
Q4 2019 Feb 14, 2020	SELL	$57.36 - $124.1 $8,202 - $17,746	-143 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $8,392 - $11,505	143 New	143 $9,000
Q2 2018 Aug 14, 2018	SELL	$60.0 - $85.67 $26,400 - $37,694	-440 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$52.72 - $67.25 $7,169 - $9,146	136 Added 44.74%	440 $27,000
Q4 2017 Feb 14, 2018	SELL	$58.2 - $72.76 $1,629 - $2,037	-28 Reduced 8.43%	304 $18,000
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $18,927 - $39,425	332	332 $19,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.